Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Keywords
(4)
Overall Survival
Phase Ii
Prostate Cancer
Randomized Controlled Trial
Subscribe
Academic
Publications
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant
Edit
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
(
Citations: 57
)
BibTex
|
RIS
|
RefWorks
Download
P. W. Kantoff
,
T. J. Schuetz
,
B. A. Blumenstein
,
L. M. Glode
,
D. L. Bilhartz
,
M. Wyand
,
K. Manson
,
D. L. Panicali
,
R. Laus
,
J. Schlom
,
W. L. Dahut
,
P. M. Arlen
http://academic.research.microsoft.com/io.ashx?type=5&id=30850077&selfId1=0&selfId2=0&maxNumber=12&query=
Journal:
Journal of Clinical Oncology - J CLIN ONCOL
, vol. 28, no. 7, pp. 1099-1105, 2010
DOI:
10.1200/JCO.2009.25.0597
Cumulative
Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
(
jco.ascopubs.org
)
Citation Context
(24)
... In a randomized Phase II trial, PROSTVAC alone significantly improved overall survival compared with a placebo in healthy, well-performing patients with mAIP
...
Serena S. Kwek
,
et al.
Unmasking the immune recognition of prostate cancer with CTLA4 blockad...
...5 months
...
Jacques Banchereau
,
et al.
Cancer immunotherapy via dendritic cells
...28,
...
Y Gao
,
et al.
Treatment with targeted vesicular stomatitis virus generates therapeut...
...A 43-center phase II randomized controlled trial of a poxviral-based PSA-targeted vaccine (PSA-TRICOM) in mCRPC also demonstrated an improvement in median OS of 8.5 months in this patient population [
5
]...
Matteo Vergati
,
et al.
Analysis of circulating regulatory T cells in patients with metastatic...
...39 prostate cance
...
J Westermann
,
et al.
Allogeneic gene-modified tumor cells (RCC26/IL7/CD80) as a vaccine in ...
Sort by:
Citations
(57)
Unmasking the immune recognition of prostate cancer with CTLA4 blockade
Serena S. Kwek
,
Edward Cha
,
Lawrence Fong
Journal:
Nature Reviews Cancer - NAT REV CANCER
, vol. 12, no. 4, pp. 289-297, 2012
Cancer immunotherapy via dendritic cells
Jacques Banchereau
,
Karolina Palucka
Journal:
Nature Reviews Cancer - NAT REV CANCER
, vol. 12, no. 4, pp. 265-277, 2012
Treatment with targeted vesicular stomatitis virus generates therapeutic multifunctional anti-tumor memory CD4 T cells
Y Gao
,
P Whitaker-Dowling
,
J A Griffin
,
I Bergman
Journal:
Cancer Gene Therapy
, vol. 19, no. 4, pp. 282-291, 2012
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman
,
Franck Pagès
,
Catherine Sautès-Fridman
,
Jérôme Galon
Journal:
Nature Reviews Cancer - NAT REV CANCER
, vol. 12, no. 4, pp. 298-306, 2012
The genomic complexity of primary human prostate cancer
(
Citations: 3
)
Michael F. Berger
,
Michael S. Lawrence
,
Francesca Demichelis
,
Yotam Drier
,
Kristian Cibulskis
,
Andrey Y. Sivachenko
,
Andrea Sboner
,
Raquel Esgueva
,
Dorothee Pflueger
,
Carrie Sougnez
,
Robert Onofrio
,
Scott L. Carter
http://academic.research.microsoft.com/io.ashx?type=5&id=53474449&selfId1=0&selfId2=0&maxNumber=12&query=
Journal:
Nature
, vol. 470, no. 7333, pp. 214-220, 2011